To overcome these limitations, Antengene developed ATG-201, a “2+1” CD19 x CD3 TCE, which was evaluated in a series of in ...

As Puffy, Diddy or Love, the mogul found success and trouble. After years of accusations with few consequences, he’ll stand ...

ZEISS Medical Technology and Boehringer Ingelheim continue to advance their research collaboration to champion data-driven ...

Pacific Edge notes the ‘Genetic Testing in Oncology: Specific Tests’ (L39365) Local Coverage Determination became effective on 24 April 2025 in the US, halting Medicare coverage of Cxbladder tests.

Q1 2025 Earnings Conference Call April 30, 2025 11:30 AM ETCompany ParticipantsWade Walke - SVP, IRBrett Monia ...

Q1 2025 Earnings Call Transcript April 29, 2025 NeoGenomics, Inc. misses on earnings expectations. Reported EPS is $-0.20352 ...

Alto Neuroscience, Inc. ("Alto") a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced multiple ...

ExoPTEN, will also be featured in a poster presentation by Dr. Isabelle Solomon and ... or maintain regulatory approval of the drug product candidates of the Company; the introduction of competing ...

Duggy the DC-3, a restored aircraft with a rich history, celebrates its 20th anniversary this year. Since joining the ...

The first movie poster was created in 1890 in France, and it did little more than announce show times, but the idea blossomed ...

Two abstracts accepted for poster presentation highlight Company’s proprietary Conditionally Active Biologic technology; Differentiated preclinical activity for CAB anti-Nectin4-antibody drug ...

Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody ... today announced the presentation of a poster at the American Association for Cancer Research (AACR) Annual ...